Blog

Joshua Muia: Two posters on the enzyme ADAMTS13 being a biomarker in sepsis at ISTH

Photo from Joshua Muia/LinkedIn

Jun 30, 2024, 12:42

Joshua Muia: Two posters on the enzyme ADAMTS13 being a biomarker in sepsis at ISTH

Joshua Muia, Associate Investigator at Versiti Blood Research Institute, posted on LinkedIn:

“I am thrilled to attend the 2024 International Society on Thrombosis and Haemostasis (ISTH) Congress ISTH2024 inBangkok, Thailand. My student Frida Miranda (Oklahoma State University, Center for Health Sciences) and I presented two posters on a newly developed multiplex assay of the enzyme ADAMTS13 and ADAMTS13 being a biomarker in Sepsis. Frida’s Outstanding Abstract was recognized with a Career Travel Award and ISTH 2021 Philadelphia Congress Local Organizing Committee Legacy Fund Award.”

Source: Joshua Muia/LinkedIn

ADAMTS13 cancer Career Travel Award International Society on Thrombosis and Haemostasis ISTH ISTH 2021 Philadelphia Congress Local Organizing Committee Legacy Fund Award Joshua Muia OncoDaily Oncology sepsis

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Giuliana Rancic and Breast Cancer: How She Went Against, How She Survived, and More

Special Coverage